Twin Peaks Wealth Advisors LLC Boosts Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Twin Peaks Wealth Advisors LLC grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 23.3% in the 3rd quarter, HoldingsChannel reports. The firm owned 603 shares of the healthcare conglomerate’s stock after purchasing an additional 114 shares during the quarter. Twin Peaks Wealth Advisors LLC’s holdings in UnitedHealth Group were worth $353,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. International Assets Investment Management LLC grew its position in UnitedHealth Group by 78,814.4% during the 3rd quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock worth $3,096,896,000 after purchasing an additional 5,290,025 shares during the last quarter. Swedbank AB acquired a new stake in shares of UnitedHealth Group in the 1st quarter worth $1,117,462,000. Mitsubishi UFJ Asset Management Co. Ltd. lifted its position in UnitedHealth Group by 107.8% in the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 2,306,729 shares of the healthcare conglomerate’s stock valued at $1,141,113,000 after purchasing an additional 1,196,758 shares during the period. Lone Pine Capital LLC purchased a new position in shares of UnitedHealth Group during the 2nd quarter worth approximately $480,903,000. Finally, Dimensional Fund Advisors LP raised its position in UnitedHealth Group by 30.0% in the second quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock worth $1,942,956,000 after acquiring an additional 880,183 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Trading Up 0.9 %

UNH stock traded up $5.32 during midday trading on Wednesday, reaching $567.45. 349,917 shares of the company’s stock traded hands, compared to its average volume of 3,902,570. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.88. The company has a market capitalization of $523.99 billion, a P/E ratio of 36.62, a PEG ratio of 1.66 and a beta of 0.58. The business has a 50-day moving average price of $582.88 and a two-hundred day moving average price of $540.32. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $608.63.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping the consensus estimate of $7.00 by $0.15. The company had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company’s revenue was up 9.2% compared to the same quarter last year. During the same quarter in the prior year, the business earned $6.56 earnings per share. Equities research analysts forecast that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were given a dividend of $2.10 per share. The ex-dividend date was Monday, September 16th. This represents a $8.40 annualized dividend and a dividend yield of 1.48%. UnitedHealth Group’s payout ratio is 54.72%.

Analyst Upgrades and Downgrades

A number of research firms recently commented on UNH. Hsbc Global Res downgraded shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Thursday, October 17th. Cantor Fitzgerald boosted their target price on UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 16th. KeyCorp began coverage on shares of UnitedHealth Group in a research note on Friday, October 11th. They issued an “overweight” rating and a $675.00 price objective on the stock. Bank of America cut their price objective on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. Finally, Robert W. Baird increased their price objective on UnitedHealth Group from $597.00 to $640.00 and gave the company an “outperform” rating in a research note on Wednesday, July 17th. Four equities research analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Moderate Buy” and an average price target of $615.53.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.